Your browser doesn't support javascript.
loading
Evidence for antibody as a protective correlate for COVID-19 vaccines.
Earle, Kristen A; Ambrosino, Donna M; Fiore-Gartland, Andrew; Goldblatt, David; Gilbert, Peter B; Siber, George R; Dull, Peter; Plotkin, Stanley A.
Affiliation
  • Earle KA; Vaccine Development & Surveillance, Bill & Melinda Gates Foundation, 500 5th Ave N, Seattle, WA 98109, USA.
  • Ambrosino DM; Independent Advisor, Stuart, FL, USA.
  • Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.
  • Goldblatt D; Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK.
  • Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.
  • Siber GR; Independent Advisor, New York, NY, USA.
  • Dull P; Vaccine Development & Surveillance, Bill & Melinda Gates Foundation, 500 5th Ave N, Seattle, WA 98109, USA. Electronic address: Peter.Dull@gatesfoundation.org.
  • Plotkin SA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, 3401 Civic Center Blvd., Philadelphia, PA 19104, USA.
Vaccine ; 39(32): 4423-4428, 2021 07 22.
Article in En | MEDLINE | ID: mdl-34210573

Full text: 1 Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Vaccine Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Vaccine Year: 2021 Type: Article Affiliation country: United States